Page last updated: 2024-08-16

sulpiride and neuropeptide y

sulpiride has been researched along with neuropeptide y in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (85.71)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SmiaƂowska, M1
Bush, LG; Gibb, JW; Hanson, GR; Midgley, LP; Singh, NA; Wagstaff, JD1
Obuchowicz, E1
Goldstein, M; Masuyama, Y; Nishio, I; Tsuda, K; Tsuda, S1
Obuchowicz, E; Turchan, J2
Dai, F; Hong, SJ; Kim, TI; Li, S; Song, JH; Won, MH; Yoo, WG1

Other Studies

7 other study(ies) available for sulpiride and neuropeptide y

ArticleYear
An inhibitory dopaminergic regulation of the neuropeptide Y immunoreactivity expression in the rat cerebral cortex neurons.
    Neuroscience, 1995, Volume: 66, Issue:3

    Topics: Animals; Benzazepines; Cerebral Cortex; Dopamine; Dopamine D2 Receptor Antagonists; Gene Expression Regulation; Haloperidol; Immunohistochemistry; Kinetics; Male; Neurons; Neuropeptide Y; Phenoxybenzamine; Propranolol; Rats; Rats, Wistar; Receptors, Dopamine D1; Reserpine; Sulpiride; Time Factors

1995
Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions.
    European journal of pharmacology, 1994, Jan-14, Volume: 251, Issue:2-3

    Topics: Animals; Basal Ganglia; Benzazepines; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extrapyramidal Tracts; Globus Pallidus; Limbic System; Male; Neurons; Neuropeptide Y; Nucleus Accumbens; Putamen; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Stimulation, Chemical; Sulpiride

1994
Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.
    Neuropeptides, 1996, Volume: 30, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Benzazepines; Chlorpromazine; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Gene Expression Regulation; Haloperidol; Hypothalamus; Male; Neuropeptide Y; Prazosin; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Sulpiride

1996
Modulation of [3H]dopamine release by neuropeptide Y in rat striatal slices.
    European journal of pharmacology, 1997, Feb-19, Volume: 321, Issue:1

    Topics: Animals; Dopamine; Dopamine Antagonists; Electric Stimulation; GTP-Binding Protein alpha Subunits, Gi-Go; In Vitro Techniques; Male; Neostriatum; Neuropeptide Y; Pertussis Toxin; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Species Specificity; Sulpiride; Virulence Factors, Bordetella

1997
Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum.
    Neuropeptides, 1998, Volume: 32, Issue:5

    Topics: Adrenergic Antagonists; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Corpus Striatum; Dopamine Antagonists; Haloperidol; In Situ Hybridization; Injections, Intraperitoneal; Male; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Dopamine; Receptors, Serotonin; RNA, Messenger; Serotonin Antagonists; Sulpiride

1998
Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 9, Issue:1-2

    Topics: Animals; Antipsychotic Agents; Chlorpromazine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Immunohistochemistry; In Situ Hybridization; Male; Neuropeptide Y; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine D1; RNA, Messenger; Substance Withdrawal Syndrome; Sulpiride; Time Factors

1999
Chemotactic migration of newly excysted juvenile Clonorchis sinensis is suppressed by neuro-antagonists.
    PLoS neglected tropical diseases, 2019, Volume: 13, Issue:8

    Topics: Animals; Benzamides; Biphenyl Compounds; Chemotaxis; Cholic Acid; Clonorchis sinensis; Dopamine; Dopamine Uptake Inhibitors; Excitatory Amino Acid Agents; Fasciola hepatica; Fluorenes; FMRFamide; Neuropeptide Y; Neurotransmitter Agents; Peptide YY; Piperazines; Serotonin Agents; Spiro Compounds; Sulpiride

2019